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Laminin 332-deficient junctional epidermolysis bul-
losa (JEB) is a severe genetic skin disease. JEB is
marked by epidermal stem cell depletion, the origin
of which is unknown. We show that dysregulation
of the YAP and TAZ pathway underpins such stem
cell depletion. Laminin 332-mediated YAP activity
sustains human epidermal stem cells, detected as
holoclones. Ablation of YAP selectively depletes
holoclones, while enforced YAP blocks conversion
of stem cells into progenitors and indefinitely ex-
tends the keratinocyte lifespan. YAP is dramatically
decreased in JEB keratinocytes, which contain only
phosphorylated, inactive YAP. In normal keratino-
cytes, laminin 332 and a6b4 ablation abolish YAP
activity and recapitulate the JEB phenotype. In JEB
keratinocytes, laminin 332-gene therapy rescues
YAP activity and epidermal stem cells in vitro and
in vivo. In JEB cells, enforced YAP recapitulates lam-
inin 332-gene therapy, thus uncoupling adhesion
from proliferation in epidermal stem cells. This work
has important clinical implication for ex vivo gene
therapy of JEB.
INTRODUCTION
Constant regeneration and repair of the human epidermis rely on
specific long-lived stem cells, which generate short-lived, tran-
sient-amplifying (TA) progenitors that undergo terminal differen-
tiation (Hirsch et al., 2017). Interfollicular stem and TA cells reside
in the epidermal basal layer and adhere to the basement mem-
brane through hemidesmosomes, specialized junctional com-2036 Cell Reports 27, 2036–2049, May 14, 2019 ª 2019 The Author(s
This is an open access article under the CC BY-NC-ND license (http://plexes linking the extracellular matrix to keratins (Walko et al.,
2015). Within hemidesmosomes, a6b4 integrins bind to laminin
332 (also known as laminin 5), a heterotrimeric protein consisting
of a3, b3, and g2 chains. In turn, laminin 332 tightens the
epidermal-dermal junction by binding to the NC-1 domain of
type VII collagen, the major component of the dermal anchoring
fibrils linking the basement membrane to anchoring plaques in
the papillary dermis (Borradori et al., 1997; De Luca et al.,
1990; Hopkinson and Jones, 2000; Rousselle et al., 1997; Son-
nenberg et al., 1991; Stepp et al., 1990).
Epidermolysis bullosa (EB) is a group of devastating, often
early lethal, genetic disorders characterized by structural and
mechanical fragility of skin and mucosal membranes. Recurrent
blistering and multiple infections, chronic skin wounds, and
disabling scarring severely impair the quality of life of EB pa-
tients (see Fine et al., 2014, 2008 for review). The most severe
forms of the disease are generalized junctional EB (JEB) and
recessive dystrophic EB (RDEB). JEB is caused by mutations
in LAMA3, LAMB3, or LAMC2 (which, together, encode laminin
332); ITGA6 and ITGB4 (encoding a6b4 integrins); andCOL17A1
(encoding collagen XVII, also known as bullous pemphigoid
antigen 2). RDEB is due to mutations in COL7A1 (encoding
collagen VII). Thus, the skin cleavage occurs within hemidesmo-
somes in JEB and within the superficial dermis in RDEB (Fine
et al., 2014). There is no cure for EB, and symptomatic treat-
ments aim at relieving the ravaging clinical manifestations.
Autologous cultures of human keratinocytes (Rheinwald and
Green, 1975) containing a defined number of stem cells have
long been used to prepare grafts that can permanently restore
massive epithelial defects, such as skin and corneal burns (Gal-
lico et al., 1984; Pellegrini et al., 1999b, 1997; Rama et al.,
2010; Ronfard et al., 2000). LAMB3-deficient JEB (hereafter
referred to as JEB) has been tackled through transplantation of
transgenic epidermal cultures (Bauer et al., 2017; De Rosa
et al., 2013; Mavilio et al., 2006). RDEB gene therapy has been).
creativecommons.org/licenses/by-nc-nd/4.0/).
developed as well (Siprashvili et al., 2016). Combined ex vivo cell
and gene therapy has proved to be lifesaving, as it was able to
regenerate virtually an entire, fully functional epidermis on a child
suffering from a devastating form of JEB with poor prognosis
(Hirsch et al., 2017). Despite the successful outcome of these tri-
als, we repeatedly observed that epidermal cells obtained from
JEB patients initiate colonies with low efficiency. Once (and if)
established, JEB cultures are often depleted of detectable stem
cells and/or show very rapid clonal conversion leading to prema-
ture stem cell depletion and replicative senescence, making
ex vivo gene therapy particularly cumbersome and sometimes
not doable. Of note, these features were particularly evident in
JEB adults and were not observed in cultures initiated from other
forms of EB. This notion prompted us to investigate whether JEB
stem cell depletion might be ascribed to a perturbation of signals
emanating from the basal keratinocyte adhesive machinery.
The Yes-associated protein (YAP) and its paralog with PDZ-
binding motif (TAZ) are transcriptional co-activators driving cell
proliferation in many types of stem and progenitor cells and can-
cers and key regulators of mechanotransduction (see Harvey
et al., 2013; Irvine and Harvey, 2015; Pan, 2010; and Piccolo
et al., 2013 for review). Unphosphorylated YAP translocates to
the nucleus, where it induces target genes through interaction
with TEAD transcription factors. Phosphorylation of YAP and
TAZ byMst1/2 and Lats1/2 kinases in defined serine residues re-
sults in their sequestration, hence functional inactivation, into the
cytoplasm by 14-3-3 proteins (Zhao et al., 2007). This molecular
system, referred to as the Hippo signaling pathway, senses
adhesion-dependent mechanical cues (see Dobrokhotov et al.,
2018; Dupont, 2016 for review).
In this paper, we show that (1) adhesion-dependent, laminin
332-mediated YAP activity is instrumental in sustaining human
epidermal stem cells; (2) JEB triggers YAP inactivation, leading
to epidermal stem cell depletion; (3) gene therapy-mediated
restoration of JEB adhesive properties rescues YAP activity
and epidermal stem cells in vitro and in vivo; and (4) enforced
YAP mimics LAMB3-gene therapy and decouples epidermal
adhesion from stemness.
RESULTS
Nuclear YAP Is Selectively Expressed in Human
Epidermal Stem Cells
An important step toward molecular definition of human
epidermal stem cells came from the discovery of p63 (Yang
et al., 1998) as a key transcription factor sustaining all squamous
epithelia (Mills et al., 1999; Yang et al., 1999). In particular,
DNp63a (hereafter referred to as p63a) underpins the prolifera-
tive, regenerative capacity of epithelial stem cells (Senoo et al.,
2007; Yang et al., 1999). In normal human skin, nuclear (active)
YAPwas detected almost exclusively in p63abright basal keratino-
cytes (Figure 1A, at arrows). The basal layer contained a mean of
30.6% ± 6.7 p63abright/YAPnuclear keratinocytes (average of 5
donors) (Figure 1A, inset). Basal p63adim and basal and supra-
basal p63aneg keratinocytes contained only cytoplasmic (inac-
tive) YAP (Figure 1A, at asterisks).
Human keratinocytes initiate different types of colonies,
referred to as holoclones, meroclones, and paraclones (Fig-ure S1; see STAR Methods) (Barrandon and Green, 1987; Pelle-
grini et al., 1999a); p63a strongly declines during clonal transition
from holoclone to meroclone, and the protein is virtually absent
in paraclones (Di Iorio et al., 2005; Pellegrini et al., 2001). Clonal
tracing of human transgenic epidermis unambiguously showed
that holoclone-forming cells are self-renewing, long-lived stem
cells underpinning the epidermis and giving rise to pools of
short-lived progenitors (meroclones and paraclones) that ulti-
mately replenish differentiated cells and contribute to wound
healing (Hirsch et al., 2017). Strikingly, the long-term clinical suc-
cess of epithelial cultures relies on a defined number of p63abright
holoclones (Pellegrini et al., 2013; Rama et al., 2010). Holoclone-
type colonies—defined as round colonies with smooth and
regular borders and formed entirely by small cells with scarce
cytoplasm—of a 4-day epidermal primary culture were formed
mainly by small p63abright keratinocytes containing nuclear
YAP (Figure 1B). At longer culture time (610 days), keratino-
cytes gather at the center of the colonies and start to stratify
and differentiate. In such colonies, nuclear YAP was expressed
by peripheral, proliferating p63abright cells (Figure 1B, at arrows),
whereas central keratinocytes contained only cytoplasmic,
inactive YAP and were either p63adim or p63aneg (Figure 1B, at
asterisks).
Of note, nuclear YAP was tightly related to the expression of
14-3-3s and a-catenin, the latter being a component of adhe-
rens junctions sensing epidermal cell density and restricting ker-
atinocyte proliferation (Schlegelmilch et al., 2011). Keratino-
cytes located at the edge of growing colonies contained
nuclear YAP and virtually undetectable 14-3-3s, while cells
crowded at the center of the colony expressed 14-3-3s and
contained only cytoplasmic YAP (Figure 1C, 14-3-3s/YAP, at
asterisks). As shown in Figure 1C (4 days), small colonies,
formed predominantly by YAPnuclear cells, expressed low
amounts of a-catenin located at cell-cell junctions (at arrow).
Actin microfilaments-enriched cells, located at the center of
growing colonies (612 days), expressed high amounts of
a-catenin and contained only cytoplasmic YAP. Note that prolif-
erating keratinocytes located at the edge of such colonies still
contained nuclear YAP and little a-catenin at cell-cell
junctions (at arrows). These data are consistent with the notion
that in murine epidermis a-catenin negatively regulates YAP
activity by modulating its interaction with 14-3-3 proteins,
particularly at high cell densities (Schlegelmilch et al., 2011;
Zhao et al., 2007).
The expression of YAP in stem cells and TA progenitors was
then investigated at a clonal level (STAR Methods; Figure S1).
We analyzed 160 clones from 5 different donors. Clonogenic ker-
atinocytes gave rise to 12.2% ± 3.85%, 64.4% ± 6.94%, and
23.3% ± 3.33% (n = 5, mean ± SD) holoclones, meroclones,
and paraclones, respectively. Clonal conversion, namely, the
transition from holoclones to paraclones, was marked by
progressive decrease of p63a, YAP, and TAZ (Figure 1D). Strik-
ingly, nuclear YAP was detected in holoclones but was virtually
undetectable in meroclones and paraclones (Figure 1E), while
cytoplasmic, phosphorylated-YAP (P-YAPSer127) was barely
detectable in holoclones and progressively increased in mero-
clones and paraclones (Figure 1F). Of note, survivin, a YAP target
inhibiting anoikis in epidermal cells, was abundantly expressedCell Reports 27, 2036–2049, May 14, 2019 2037
Figure 1. Expression of YAP in Normal Hu-
man Keratinocytes
(A) Immunofluorescence analysis of p63a and YAP
expression in 7-mm-thick skin sections prepared
from healthy donors (WT-1 and WT-2). Nuclear YAP
is contained in basal keratinocytes expressing high
levels of p63a (arrows). The inset shows the per-
centage of p63abright/YAPnuclear cells in the
epidermal basal layer (n = 5 WT donors, age 2279
years). The p63adim and suprabasal keratinocytes
contain cytoplasmic YAP (asterisk). Nuclei are
stained with DAPI. Dotted line marks the epidermal-
dermal junction. Scale bars, 40 mm.
(B) Immunofluorescence analysis of p63a and YAP in
holoclone-type colonies derived from healthy do-
nors at 4, 6, and 10 days of cultivation. The 4-day
colonies are formed mainly by p63abright/YAPnuclear
cells. In 6- to 10-day colonies, nuclear YAP is
contained in p63abright cells (arrows) at the edge
the colonies, while the central part of such pro-
gressively growing colonies is formed mainly by
keratinocytes containing cytoplasmic YAP (asterisk).
Dotted line marks the colony perimeter. Scale bars,
20 mm.
(C) Top: normal keratinocytes (WT) in the central part
of 10-day colonies contain cytoplasmic YAP and 14-
3-3s (asterisks), which is not detected in YAPnuclear
cells located at the edge of the colonies (arrows).
Bottom: YAPnuclear cells express low amounts of
a-catenin located at cell-cell junctions (arrows). Cells
located at the center of growing 6- to 12-day colonies
express high levels of a-catenin and contain only
cytoplasmicYAP.Scalebars, 20mm(4-6days); 10mm
(12 days).
(D) Western analysis of total cell extracts from cul-
tures generated by holoclones (H), meroclones (M),
and paraclones (P) isolated by clonal analysis (see
STAR Methods and Figure S1) of sub-confluent
normal human primary keratinocyte cultures. Clonal
conversion is marked by progressive decrease of
p63a, YAP and TAZ, and survivin (YAP target).
(E) Western analysis of nuclear cell extracts shows
that nuclear YAP is detected exclusively in hol-
oclones (H). Histone H3 was used as loading con-
trol.
(F) Top: western analysis of total cell extracts from
cultures generated by H, M, and P shows that clonal
conversion is marked by progressive increase of
serine127-phosphorylated (inactive) YAP. Bottom:
the pYAP/YAP ratio observed during clonal conver-
sion. Total YAP was used as loading control.in holoclones, barely detectable in meroclones, and undetect-
able in paraclones, hence mirroring the expression of nuclear
YAP (Figures 1D and 1E).
YAP Sustains Epidermal Stem Cells and Regulates
Clonal Conversion
We ablated YAP and TAZ in short- and long-term assays by
means of specific small interfering RNA (siRNA) and short hairpin
RNA (shRNA) (STAR Methods). In short-term (48 h) assays,
neither siRNA-YAP nor siRNA-TAZ was able to significantly
modulate the expression of p63a, although survivin slightly
decreased in cells exposed to siRNA-YAP. Strikingly, simulta-2038 Cell Reports 27, 2036–2049, May 14, 2019neous ablation of YAP and TAZ completely abolished the
expression of both p63a and survivin (Figure S2A).
Primary keratinocytes were stably transduced with a lentiviral
vector carrying specific YAPmicroRNA-adapted shRNA under a
Tet-promoter and TAZ microRNA-adapted shRNA under a
hCMV-promoter (STAR Methods). As compared to mock-trans-
duced cells (shCtr1/2), YAP short hairpin RNA (shYAP) and TAZ
short hairpin RNA (shTAZ) reduced the expression of YAP and
TAZ of 90% and 70%, respectively (Figure 2A). Note that
downregulation of YAP and TAZ induced amutual compensating
increase of the paralog, more evident with shYAP (Figure 2A). As
with siRNA-YAP and -TAZ (Figure S2A), these mutual offsetting
Figure 2. Downregulation of YAP and TAZ
(A) Western blot was performed on total protein extracts isolated from normal human keratinocytes transduced with TRIPZ-inducible lentiviral shRNA (YAPa/b and
Ctr1) and GIPZ-lentiviral shRNA (TAZa/b and Ctr2). Control cells were co-transduced with Ctr1 and Ctr2. Asterisks indicate samples used for further analysis.
Doxycycline (0.5 mg/ml) was used to induce shRNA expression.
(B) qRT-PCR on mRNAs obtained from keratinocytes transduced with different shRNAs was used to determine the expression of 2 different YAP target genes
(CTGF and BIRC5) (n = 3; mean ± SD). GAPDH mRNA was used to normalize the RT-PCR.
(C) Colony forming efficiency (CFE; left) and percentage of aborted colonies (right) were evaluated on keratinocytes transduced with different shRNA (as
indicated). Doxycycline (0.5 mg/ml) was added 24h after transduction. Assays were performed at the first passage (7 d after transduction) (n = 2; mean ± SD).
(D) Left: clonal analysis of shRNA transduced clonogenic keratinocytes (see STAR Methods). Only the double positive clones (shCtr1/shCtr2, shYAP/shCtr2,
shTAZ/shCtr1, and shYAP/shTAZ) were selected for clonal analysis. Middle: note that holoclones (H, red) could not be detected in shYAP transduced cultures,
which still generated meroclones (M, light blue) and paraclones (P, gray). Keratinocytes co-transduced with shYAP and shTAZ generated virtually only para-
clones. Right: representative cultures generated by these transduced clones.effects explain the almost normal expression of TAZ in many
double shYAP/shTAZ-transduced cultures (Figure 2A). Further
experiments were thus performed with specific shYAP and
shTAZ (Figure 2A, asterisks), which determined significant abla-
tion of both YAP and TAZ and repression of their target genes
CTGF and BIRC5 (survivin) (Figures 2A and 2B).
As shown in Figure 2C (left panel), shCtr- and shTAZ-trans-
duced cultures had a similar colony forming efficiency (CFE),
whereas shYAP caused an over 50% decrease of clonogenic
cells. But neither shRNAs significantly fostered clonal conver-
sion, as indicated by a similar percentage of aborted colonies
observed in shCtr, shYAP, and shTAZ (Figure 2C, right panel).
Strikingly, simultaneous ablation of YAP and TAZ dramatically
decreasedCFE and generated only aborted colonies (Figure 2C).
Thus, the clonogenic ability of YAP- and TAZ-ablated cells van-
ished in a single cell passage, and cells underwent growth arrest
(see also Figure S2B).
Clonal analysis was then performed on primary cultures trans-
duced with (1) shCtr1/shCtr2, (2) shCtr2/shYAP, (3) shCtr1/
ShTAZ, and (4) shYAP/shTAZ (STAR Methods). Colonies were
identified by Turbo-RFP (shCtr1 and shYAP) and Turbo-EGFP(shCtr2/shTAZ). A total of 262 double-colored clones were
analyzed: 83 clones were transduced with shCtr1/2; 52 and 59
clones were transduced with shCtr2/shYAP or shCtr1/shTAZ,
respectively; and 68 clones were transduced with shYAP/shTAZ
(Figure 2D, left). Each clone was transferred to an indicator dish
for the classification of clonal type (Figure 2D, left; see also STAR
Methods). As shown in Figure 2D (middle), a similar percentage
of holoclones, meroclones, and paraclones was detected in
shCtr1/2 and shTAZ-transduced cells. Strikingly, ablation of
YAP induced the selective disappearance of holoclones and a
significant decrease of meroclones and increase of paraclones.
Keratinocytes transduced both with shYAP and shTAZ gener-
ated virtually only paraclones. Figure 2D (right panel) shows
representative cultures generated by these transduced clones.
These data confirm that simultaneous YAP and TAZ ablation
totally abolishes keratinocyte clonogenic ability and points to a
critical role of YAP in upholding human epidermal stem cells.
Primary keratinocytes were then transduced with lentiviral
vectors expressing Tet-inducible FLAG-YAP constructs,
namely, YAP, YAP5SA (a constitutively active YAP), YAPS127A
(carrying alanine substitution for Ser127, which abolishes theCell Reports 27, 2036–2049, May 14, 2019 2039
Figure 3. Enforced Expression of YAP and YAP Mutants
(A) Top: primary epidermal cultures were transduced with Tet-inducible lentiviral vectors carrying EGFP or the indicated FLAG-YAP constructs. Sub-confluent
cultures were stained with FLAG-specific and keratin 14 (Krt14) antibodies. Middle: the same cultures were stained for b-galactosidase. Bottom: their colony
forming efficiency (CFE) was determined.
(B) Western analysis of total cell extracts from YAPS127A- and YAP5SA-transduced cultures shows that premature replicative senescence was confirmed by
upregulation of p53 and p16INK4a (and downregulation of p63a).
(C) Serial cultivation of EGFP- (green) and YAP-transduced (red) epidermal cultures. Top: CFE values are expressed as the ratio of the total number of colonies on
the number of inoculated cells. All colonies were scored whether progressively growing or aborted. Middle: percentage of aborted colonies on the total number of
colonies. Bottom: growth rate was calculated as population doublings per passage (see STAR Methods). YAP-transduced cultures show bypass of replicative
senescence and indefinite proliferative potential.
(D and E) Clonal analysis of EGFP- and YAP-transduced epidermal cultures. The percentage of holoclones (H, red), meroclones (M, light blue), and paraclone
(P, gray) has been calculated at the indicated cell passages (p). In YAP-transduced cells, the percentage of holoclones and the H/M/P ratio remained stable even
at p36, while no clones were detected at p26 in EGFP-transduced cells. The block of clonal conversion was abolished upon removal of Doxycyclin (at p36), and
YAP-transduced cultures lost their holoclones (D) as well as their clonogenic ability (E) after 4 passages.interaction of YAPwith 14-3-3s), and YAPS94A (amutant unable
to bind TEAD transcription factors).
Although enforced YAP remained largely confined to the
cytoplasm (Figure 3A, upper panel), the fraction of exogenous
YAP able to move to the nucleus was transcriptionally active
(Figure S3A). YAP induced a small increase of the keratinocyte
clonogenic ability (Figures 3A, lower panel, and S3B); yet, it
dramatically boosted their proliferative potential. The EGFP-
transduced keratinocytes underwent 180 cell generations before
senescence, which occurred after 27 cell passages. In contrast,
YAP-transduced keratinocytes readily bypassed replicative
senescence and continued to divide indefinitely. To date, they
underwent 268 cell doublings and have been passaged 42 times.2040 Cell Reports 27, 2036–2049, May 14, 2019Of note, serial cultivation of YAP-transduced cells clearly
demonstrated that the extension of their lifespan (or even poten-
tial immortalization) was not marked by a progressive increase of
the clonogenic ability or a progressive decrease of aborted
colonies. Indeed, YAP-transduced keratinocytes at early and
late cell passages had similar CFE (Figure 3C, upper panel)
and contained a similar number of aborted colonies (Figure 3C,
middle panel). Furthermore, YAP did not increase keratinocyte
growth rate, which remained unchanged during the long serial
cultivation and was comparable to that of early passages of
EGFP-transduced cells (Figure 3C, lower panel). Strikingly, the
initial percentage of holoclones, meroclones, and paraclones
remained unchanged in YAP-transduced keratinocytes at p4
and p36 (Figure 3D). In contrast, clonal conversion occurred in
EGFP-transduced cells, and no EGFP colonies could be de-
tected already at p26 (Figure 3D).
These data show that YAP regulates neither keratinocyte
growth rate nor their clonogenic ability. YAP halts clonal conver-
sion, forcing keratinocytes into the stem cell compartment,
hence extending indefinitely their proliferative potential. This
blockage is indeed reversible, inasmuch as removal of doxycy-
cline was marked by the progressive disappearance of holo-
clones (andmeroclones) (Figures 3D and 3E), leading to a senes-
cent culture containing virtually only aborted colonies, as with
EGFP-transduced cultures.
Extending keratinocyte lifespan without altering the pro-
portion of the different clonal types (Figure 3D) strongly sug-
gests that YAP does not induce clonal reversion and hence
does not revert an epidermal progenitor into a stem cell.
This notion was confirmed by enforcing YAP into clonally iso-
lated meroclones and paraclones (Figure S3D, upper panel).
Both short-term (1 week) and constitutive overexpressions
of YAP neither increased the proliferative potential of mero-
clones and paraclones (Figure S3D) nor halted their clonal
conversion, inasmuch as the percentage of aborted colonies
progressively increased both in the presence and in the
absence of doxycycline (Figure S3E) and never reached the
value of 5% (Figure S3E, dot lines) that defines holoclones
(Figure S1).
These findings strengthen the notion that YAP specifically sus-
tains holoclones, halting their clonal conversion and fostering
their self-renewal. YAP executes these biological effects through
canonical TEAD transcription factors, as keratinocytes trans-
duced with the YAPS94A reduced their clonogenic ability (Fig-
ure S3B) and showed an increase of aborted colonies and down-
regulation of p63a and survivin (Figure S3C). This phenotype
suggests a dominant-negative effect of enforced YAPS94A on
YAP in keratinocytes, as reported in other cell types.
In sharp contrast to YAP, constitutively active YAP5SA and
YAPS127Ahadacatastrophiceffectonkeratinocytesand induced
their almost-immediate growth arrest (Figures 3A and S3F). Both
mutants were located in the nuclei (Figure 3A, upper panel),
potently induced YAP target genes (Figure S3A) and a strong
decrease of clonogenic ability, which was dramatic in YAP5SA-
transduced cells (Figure 3A, lower panel). Both YAP5SA- and
YAPS127A-transduced keratinocytes displayed hallmarks of
premature replicative senescence, which is envisaged as a
potent tumor-suppressive mechanism that can be triggered
in response toaggressivemitogenic stimuli or oncogenes (Serrano
et al., 1997). Indeed, YAP5SA- and YAPS127A-transduced
keratinocytes increased their size, expressed b-galactosidase
(Figure 3A middle panel), and overexpressed p16INK4a and p53
(Figure 3B).
YAP Dysregulation and Stem Cell Loss in JEB
The notion that basal clonogenic keratinocytes adhere to the
basement membrane and their intermediate filaments contribute
to hemidesmosomes prompted us to investigate whether lami-
nin 332-dependent adhesion defects could impinge on the
YAP pathway, hence explaining stem cell loss and/or rapid
clonal conversion of JEB cultures.Two RDEB patients (9- and 12-year-olds) and 5 patients with
generalized JEB (STAR Methods) were included in this study.
JEB-1, JEB-4, and JEB-5 were 37, 49, and 26 years old, respec-
tively, while JEB-2 and JEB-3 were 7 years old and 3months old,
respectively. Type VII collagen and laminin 332 were highly
reduced in RDEB and JEB patients, respectively (see Bauer
et al., 2017; Hirsch et al., 2017; Mavilio et al., 2006; and Fig-
ure S4A). Because of limited access to patients’ specimens,
not all experiments reported hereafter were performed on sam-
ples obtained from all 5 JEB patients.
In normal skin, nuclear YAP was expressed almost exclusively
in p63abright basal keratinocytes (Figure 4A). In contrast, basal
JEB keratinocytes contained mostly cytoplasmic YAP (Fig-
ure 4A). Of note, p63abright keratinocytes were still present in
infants’ skin sections (JEB-3), less represented in children
(JEB-2), and barely detectable in adult patients (JEB-1).
YAP, TAZ, p63a, and survivin were dramatically decreased in
JEB, but not RDEB, primary cultures (Figure 4B). As observed in
normal mero and paraclones (Figure 1F), JEB cultures contained
mostly phosphorylated YAP (Figure 4B). JEB cultures also con-
tained p16INK4a, which was barely detectable in normal and
RDEB cultures (Figure 4B), suggesting a premature clonal con-
version. Normal and RDEB colonies contained a mixed popula-
tion of YAPnuclear/p63abright and YAPcytoplasmic/p63adim/null cells
(Figure 4C, wild type [WT] and RDEB), while JEB colonies
were formed mostly by keratinocytes containing cytoplasmic
YAP (Figure 4C, JEB-3 and S4B). Similarly to what was
observed in skin sections, some residual p63abright keratino-
cytes were still present in cultures from JEB infants (Figure 4C,
JEB-3), but they progressively decreased in colonies generated
from JEB children and adults (Figure S4B, JEB-2 and JEB-1).
Accordingly, normal and RDEB cultures had comparable prolif-
erative potential, which was dramatically decreased in JEB
cultures (Figure 4D).
The residual proliferative capability of JEB cultures (Figure 4D)
is highly reminiscent of the proliferative potential typically
observed in clonally isolated meroclones and paraclones (Pelle-
grini et al., 1999a) (see also Figure S3D), strongly suggesting a
selective loss of holoclone-forming cells. Indeed, clonal analysis
showed that the small percentage of holoclones still detected in
primary JEB-2 cultures vanished in a few passages (Figure 4E).
Very few holoclone-forming cells could be detected in JEB-1,
but only after multiple clonal analyses (Mavilio et al., 2006). Of
note, JEB cultures unveiled a dramatic decrease of b4, but not
of b1, integrins (Figure 4F), even if both integrins can act as lam-
inin 332 receptors.
Thus, JEB is marked by a progressive depletion of holoclone-
forming cells, phenocopying YAP-ablated normal keratino-
cytes. JEB features were recapitulated by short-term downre-
gulation of the b3 chain of laminin 332 in normal keratinocytes
by means of specific siRNA. As shown in Figure S4C, three
different siRNAb3s rapidly abolished the expression of YAP,
p63a, and survivin, and cells contained almost exclusively
cytoplasmic P-YAP. Of note, TAZ increased in such cells, sup-
porting the notion that downregulation of YAP induces a
compensating increase of the paralog (Figure S4C). However,
TAZ did not prevent siRNAb3-induced downregulation of
p63a (Figure S4C).Cell Reports 27, 2036–2049, May 14, 2019 2041
Figure 4. YAP Dysregulation in JEB
(A) Immunofluorescence analysis of p63a and YAP expression in 7-mm-thick skin sections prepared from normal skin (WT) and LAMB3-deficient JEB patients
(see STAR Methods for patients’ details). Low expression of cytoplasmic YAP marks JEB keratinocytes. DAPI (blue) stains nuclei. Dotted line marks the
epidermal-dermal junction. Scale bars, 40 mm.
(B) Western analysis of total cell extracts from WT, RDEB, and JEB cultures immunostained with indicated antibodies.
(C) Immunofluorescence analysis of p63a and YAP in 5-day primary colonies derived from healthy donors (WT) and RDEB-1 and JEB-3 patients. JEB-3-LAMB3
showscolonies initiatedafter gene therapyof JEB-3cultures (cells transducedwithagRVvectorcarryingawild-typeLAMB3cDNA,seemain text). Scalebars,10mm.
(D) Serial cultivation and calculation of cumulative cell doublings in WT (black), RDEB (gray), JEB (light gray), and LAMB3-corrected JEB (green) cultures. The
number of cell doublings was calculated as described in STAR Methods (JEB-4, n = 3; JEB-5, n = 2, JEB2, n = 2, mean ± SD).
(E) Clonal analysis of WT, JEB, and LAMB3-corrected JEB cultures. The percentage of holoclones (H, red), meroclones (M, light blue), and paraclone (P, gray) has
been calculated at the indicated cell passages (p).
(F) Western analysis of total cell extracts from WT, JEB, and LAMB3-corrected JEB cultures immunostained with indicated antobodies (similar results were
obtained with other JEB cultures).
(G) CFE of keratinocyte cultures initiated from normal skin (WT) and RDEB and JEB patients before (control [CTR]) and after genetic correction (LAMB3).Gene Therapy Restores Functional YAP and Rescues
Epidermal Stem Cells
Primary JEB keratinocytes were transduced with clinical-grade
gamma retroviral vectors (gRV) expressing full-length LAMB3
cDNA under the control of the Moloney leukemia virus long ter-
minal repeat. Transduction efficiency of clonogenic cells was
over 95%, as indicated by immunofluorescence analysis of
transgenic colonies (Bauer et al. 2017; Hirsch et al., 2017;Mavilio
et al., 2006). LAMB3-transduced JEB cultures expressed normal
levels of laminin 332-b3 (Figure 4F). Genetic correction of JEB
keratinocytes induced (1) expression of YAP and TAZ, p63a,
and survivin (Figure 4F); (2) nuclear translocation of YAP and its
co-localization with p63a (Figure 4C, LAMB3-JEB-3 and S4B);
(3) restoration of b4 integrins (Figure 4F); and (4) restoration of2042 Cell Reports 27, 2036–2049, May 14, 2019keratinocyte clonogenic ability (Figure 4G) and proliferative
potential (Figure 4D). All these parameters were comparable to
those of normal keratinocytes. Finally, LAMB3-gene therapy
rescued JEB epidermal stem cells when the transduction
occurred at early cell passages (p2). As shown in Figure 4E,
the few holoclones present in primary JEB-2 cultures were lost
already in few passages. In contrast, LAMB3-corrected cultures
preserved a percentage of holoclone-forming cells comparable
to that of a normal control during serial cultivation (Figure 4E).
Enforced YAP Recapitulates Gene Therapy of LAMB3-
JEB and Decouples Cell Adhesion from Stemness
Enforced YAP and LAMB3-gene were equivalent in restoring
expression of p63a and survivin (Figure 5A), clonogenic ability
Figure 5. Enforced YAP Recapitulates
LAMB3 Gene Therapy
(A) Western analysis of total cell extracts from Tet-
inducible EGFP and FLAG-YAP transduced JEB
cultures immunostained with indicated antibodies.
(B and C) CFE (B) and proliferative potential (C) of
JEB keratinocytes transduced with EGFP,
LAMB3, and YAP. The CFEwas plated at a density
of 1000 cells per dish, and colonies were stained
with Rhodamine B 12 days later. The number of
cell doublings was calculated as described in
STAR Methods.
(D) Top: adhesion of confluent cultured epidermal
sheets prepared from normal keratinocytes (WT)
and JEB cultures transduced with Tet-inducible
EGFP, LAMB3, and YAP. The mere trans-
portation of the flask from the incubator to the
hood caused the spontaneous detachment of
JEB and JEB-YAP cultures (arrows), while
LAMB3-corrected keratinocytes remained firmly
attached to the substrate (asterisks). Bottom:
CFE performed on the above cultures. The CFE
was plated at a density of 2.000 cells per dish,
and colonies were stained with Rhodamine B
12 days later.
(E) Clonal analysis of the cultures of (D). WT, JEB,
and LAMB3-corrected JEB cultures. The per-
centage of holoclones (H, red), meroclones
(M, light blue), and paraclone (P, gray) has been determined. Note that enforced YAP in a LAMB3 null background prevents the stem cell loss, even in the
absence of cell adhesion.
(F) Western analysis of total cell extracts from normal keratinocytes co-transfected with the indicated combinations of siRNA for a6, b4, and b1 integrins (see
Table S3) and immunostained with indicated antibodies.(Figure 5B), and proliferative potential (Figure 5C) of JEB
keratinocytes.
Of note, YAP-mediated effects occurred even in the presence
of defective adhesion. Normal keratinocyte colonies eventually
fuse, giving rise to a cohesive epidermal sheet that remains firmly
attached to the vessel (Figure 5D, WT), from which it can only be
released after prolonged (3040 min) enzymatic treatment with
the neutral proteases Dispase II (Gallico et al., 1984; Green
et al., 1979; Hirsch et al., 2017; Pellegrini et al., 1999b). Dispase
II can detach in situ epidermis from the underlying dermis as
well. In contrast, epidermal sheets generated by JEB colonies
spontaneously detached from the culture vessel (even during
the mere transportation from the incubator to the hood) and
lost their clonogenic ability (Figure 5D, EGFP). Thus, as with
normal skin, the basal layer of fully differentiated cultured
epidermis requires the interaction of basal keratinocytes with
properly assembled heterotrimeric laminin 332. Indeed, when
LAMB3-corrected JEB keratinocytes became confluent and
stratified, the resulting epidermal sheet remained firmly attached
to the culture vessel, required prolonged Dispase II treatment for
detachment and maintained a clonogenic ability similar to that of
a normal control (Figure 5D, LAMB3). Enforced YAP did not
restore the adhesive properties of JEB epidermal sheets but fully
preserved their clonogenic ability (Figure 5D, YAP).
Strikingly, enforced YAP sustained JEB holoclone-forming
cells to a similar extent of LAMB3-gene therapy (Figure 5E)
even after epidermal detachment, thus decoupling epidermal
adhesion from stemness.Laminin 332, Integrins, and YAP in JEB
The notions that (1) JEB colonies, if established, are able to grow
and reach confluence; (2) confluent JEB epidermal sheets spon-
taneously detach from the vessel and lose their clonogenic ability
at once; and (3) enforced YAP can preserve clonogenic cells of
confluent sheets in the absence of adhesion confirm that
growing keratinocyte colonies, mimicking wound healing rather
than epidermal homeostasis, use a different adhesionmachinery
than that used by fully mature epidermis (DiPersio et al., 2016).
For instance, human keratinocytes use mostly b1 integrins
during initial adhesion, migration, and growth, while a6b4 integ-
rins are uniquely located in hemidesmosomes and mediate the
firm adhesion of basal keratinocytes to the basement membrane
(Borradori et al., 1997; De Luca et al., 1990; Hopkinson and
Jones, 2000; Rousselle et al., 1997; Sonnenberg et al., 1991;
Stepp et al., 1990). Indeed, mutations in ITGA6 and ITGB4 (en-
coding a6b4), but not ITGB1 (encoding b1 integrins), give rise
to a form of JEB virtually indistinguishable from LAMB3-deficient
JEB (Fine et al., 2008).
This prompted us to investigate whether YAP expression was
modulated by b1 or b4 integrins, both of which are able to bind
laminin 332 (DiPersio et al., 2016; Rousselle and Beck, 2013).
Laminin 332-deficient JEB is marked by a concomitant downre-
gulation of a6b4 (Figure 4F; De Rosa et al., 2013; Hirsch et al.,
2017) due to both reduced transcription and increased protein
degradation (Matsui et al., 1998; McMillan et al., 1997; Ryan
et al., 1999). Such a6b4 downregulation was not accompanied
by a concomitant downregulation of b1 integrins (Figure 4F). InCell Reports 27, 2036–2049, May 14, 2019 2043
Figure 6. Laminin 332 Supports JEB Cell Growth and Clonogenic Properties
(A) WT and JEB cells were inoculated on uncoated and laminin 332-coated dishes (2.5 mg/ml) (5001000 cells per dish) (see STARMethods). Top left: CFE values
are expressed as the ratio of the total number of colonies on the number of inoculated cells. Top right: percentage of aborted colonies on the total number of
colonies. Bottom left: number of cells recovered after 12 days of cultivation. Bottom right: mean of the area of the colonies (n = 3, mean ± SD).
(B) Immunofluorescence analysis of YAP in WT, JEB, and LAMB3-corrected JEB cells plated on uncoated dishes and of JEB keratinocytes plated on laminin
332-coated dishes (JEB-Ln332). Note the nuclear localization of YAP in cells at the edge of the colonies, both in laminin 332-coated dishes and in LAMB3-
corrected cells (arrows). DAPI (blue) stains nuclei.normal keratinocytes, siRNA-mediated downregulation of a6b4,
but not b1, integrins induced a downregulation of YAP and its tar-
gets (Figures 5F and S5A). Strikingly, downregulation of b1 integ-
rins induced a concomitant upregulation of a6, which deter-
mined a concomitant increase of the expression of YAP and its
target genes in the presence of normal expression of laminin
332 (Figure S5A). Taken together, these findings show that the
interaction of laminin 332 with a6b4, but not b1, integrins is
instrumental for the function of YAP both in JEB and in normal
epidermal homeostasis and strengthen the notion that migrating
keratinocytes can use b1 integrins for their interaction with
collagen, fibronectin, and other cell-derived extracellular matrix
proteins independently of YAP (see Rousselle and Beck, 2013
for review).
Based on this notion, we investigated whether cultivation of
primary JEB epidermal cells could be improved by coating
culture vessels with recombinant laminin 332. As shown in
Figure 6A (upper panels), no significant difference was de-
tected in the number of clonogenic cells and aborted colonies
both in normal and in JEB keratinocytes grown on laminin
332. However, both colony size and cell yield were signifi-
cantly higher when JEB keratinocytes were cultured on laminin
332-coated vessels (Figure 6A, lower panels). As expected,
JEB keratinocytes located at the edge of colonies cultured
on coated vessels contained nuclear YAP, which was instead
undetectable in cells grown on uncoated dishes (Figure 6B). Of
note, normal keratinocytes cultured on coated dishes gener-2044 Cell Reports 27, 2036–2049, May 14, 2019ated larger colonies but not a higher number of cells (Figure 6A,
lower panels).
Combined Ex Vivo Cell and Gene Therapy Restores YAP
Function In Vivo
JEB has been tackled by combined ex vivo cell and gene ther-
apy. Three patients were treated with autologous epidermal cul-
tures transduced with a gRV expressing full-length LAMB3
cDNA (Bauer et al., 2017; De Rosa et al., 2013; Hirsch et al.,
2017; Mavilio et al., 2006).
At admission, basal keratinocytes of these patients contained
barely detectable amounts of b3-laminin 332 and p63a and virtu-
ally only cytoplasmic YAP (Figure 7). At 3–12 years after trans-
plantation of transgenic epidermal cultures, the regenerated
epidermis was normal-looking, remained mechanically stable
throughout the entire follow-up period, and did not form blisters,
even upon shear force. We observed a proper expression and
location of laminin 332 in the basal lamina (refs and Figure 7).
In situ hybridization performed using vector-specific LAMB3
probes showed homogeneous expression of LAMB3 mRNA in
all epidermal layers, confirming that the regenerated epidermis
consists only of transgenic keratinocytes (Bauer et al. 2017; De
Rosa et al., 2013; Hirsch et al., 2017). Histological analysis
showed a normal and fully differentiated epidermis with a normal
dermal-epidermal junction. Electron Microscopy confirmed the
presence of well-defined, organized hemidesmosomes compa-
rable to those of healthy controls (Bauer et al. 2017; De Rosa
Figure 7. Combined Cell and Gene Therapy Rescues YAP Activity In Vivo
Immunofluorescence analysis of laminin 5 (b3 chain), p63a, and YAP expression in 7-mm-thick skin sections prepared from JEB-1 and JEB-2 patients before
(admission) and after (6.5 years and 8 months, respectively) combined cell and gene therapy (b3 corrected; see De Rosa et al., 2013 and Hirsch et al., 2017 for
details). Note restoration of the expression of p63a and YAP, both contained in the nuclei (stained with DAPI) of basal keratinocytes. Dotted line marks the
epidermal–dermal junction. Scale bars, 20 mm.et al., 2013; Hirsch et al., 2017). As shown in Figure 7, the basal
layer of the newly formed transgenic epidermis contained a num-
ber of YAPnuclear/p63abright cells similar to that of a normal skin
(Figure 1A).
DISCUSSION
The boundary between the epidermis and the underlying dermis
is established by the basement membrane. Polarized keratino-
cytes of the epidermal basal layer are anchored to the basement
membrane by a variety of integrin receptors (Margadant et al.,
2010; Watt, 2002). Particularly during cell migration and wound
healing, b1 integrins provide transmembrane connections to
the intracellular actin network through recruitment of several
factors to their cytoplasmic tails (Simpson et al., 2011). Instead,
a6b4 integrin has a unique role in organizing large adhesion com-
plexes called hemidesmosomes. From one side, a6b4 is teth-
ered to intermediate filaments by plectin and bullous pemphigoid
antigens (BP180); from the other side, it binds to laminin 332,
thereby linking keratins to collagen VII dermal anchoring fibrils.
Of note, integrin complexes also transduce external cues into
intracellular signals (Simpson et al., 2011). In doing so, junctional
and cytoskeletal proteins control the maintenance of the stem
cell population that resides in the epidermal basal layer.
JEB is due to mutations in genes coding for basically all the
proteins forming hemidesmosomes, as laminin 332, a6b4 integ-rin, and collagen XVII (BP180). At variance with RDEB, laminin
332-dependent JEB is characterized by a depletion of stem cells
(Mavilio et al., 2006). Here, we show that such depletion can
be attributed to a dysregulation of the YAP and TAZ pathway.
YAP-dependent preservation of epidermal stem cells requires
integrity of the hemidesmosomal protein complex. Deleterious
mutations of LAMB3 and consequent laminin 332 ablation and
disruption of its interaction with a6b4 lead to a dramatic
decrease of YAP expression and to its translocation into the
cytoplasm, thereby causing depletion of holoclone forming cells,
which cannot be offset by TAZ. Accordingly, ablation of YAP
induces the disappearance of holoclones in normal epidermal
cultures. Our data explain the initial ability of JEB skin to heal
the recurrent lesions and of established JEB colonies to prolifer-
ate, most likely through b1 integrins. The increase of CFE and cell
yield observed when JEB keratinocytes were cultured on laminin
332-coated vessels is consistent with the notion that b1 integrin-
mediated keratinocyte spreading, migration, and proliferation
occurring during wound healing or cultivation still require laminin
332. Indeed, it has been reported that wounding of quiescent
epidermis initiates adhesion and spreading of keratinocytes at
the wound edge on endogenous basement membrane laminin
332 via both a3b1 and a6b4. The interaction of a6b4 with newly
synthesized laminin 332 culminates in collagen digestion, lami-
nin 332 deposition under the newly formed epidermis, and
consequent hemidesmosome formation (Decline and Rousselle,Cell Reports 27, 2036–2049, May 14, 2019 2045
2001; Frank and Carter, 2004; Gonzales et al., 1999; Hamelers
et al., 2005; Nguyen et al., 2000). Then, laminin 332 and its bind-
ing to a6b4 sustains the newly formed epidermis and its stem
cell population, and YAP is instrumental in this process. Indeed,
the development in the long term of chronic non-healing lesions
is marked by stem cell depletion. Accordingly, mutations of
a6b4, but not b1 integrins, cause a form of JEB virtually indistin-
guishable from LAMB3-deficient JEB (Fine et al., 2008).
Strikingly, enforced YAP can decouple adhesion from stem-
ness, inasmuch as JEB keratinocytes overexpressing YAPmain-
tain their stem cell content even in the absence of adhesion to the
substrate.
Our data are consistent with the notion that YAP regulates
murine and human epithelial stem cells (Barry et al., 2013;
Schlegelmilch et al., 2011; Walko et al., 2017; Zhang et al.,
2011; Zhao et al., 2007). In murine epidermis, a-catenin, a
molecule sensing cell density in the skin, negatively controls
YAP activity and phopsphorylation by modulating its interaction
with 14-3-3s (Schlegelmilch et al., 2011). In line with these
findings, in human keratinocytes, nuclear YAP is contained in
14-3-3sneg a-catenindim cells located at the edge of growing
colonies, while keratinocytes crowded in the central part of
the colonies express abundant a-catenin and 14-3-3s and
contain only cytoplasmic, inactive P-YAP. Unraveling the role
of YAP in regulating epidermal stem cells accounts for the
intriguing observation that downregulation of 14-3-3s forces
human keratinocytes into the stem cell compartment and fos-
ters immortalization of primary human epidermal cells without
the need of exogenous oncogenes and/or oncoviruses (Dellam-
bra et al., 2000). Accordingly, mice carrying a loss of function
mutation in 14-3-3s show unregulated nuclear YAP activity,
epidermal progenitor expansion, and inhibition of differentiation
(Sambandam et al., 2015).
When somatic cells register a preset number of generations,
known as the Hayflick limit, they enter an irreversible state of
growth arrest referred to as replicative senescence (Serrano
et al., 1997). Clonal conversion and a precise cell-doubling clock
control the timing of human keratinocyte replicative senescence
(Barrandon and Green, 1987; Dellambra et al., 2000; Pellegrini
et al., 1999a; Rochat et al., 1994). Serial propagation of keratino-
cytes is sustained by stem cells, and senescence occurs when
the last stem cell present in culture loses its stemness and gen-
erates terminal colonies (Mathor et al., 1996). YAP halts clonal
evolution and indefinitely preserves the original population of
holoclone-forming cells but does not induce clonal reversion of
meroclones into holoclone-forming cells. Thus, YAP is essential
for self-renewal and proliferative potential of epidermal stem
cells but does not induce clonal reversion of TA progenitors
into bona fide stem cells.
YAP regulates identity, maintenance, and self-renewal of
murine airway epithelial cells by functionally and genetically
interacting with p63 (Zhao et al., 2014), a critical regulator of
the proliferative potential of many epithelial stem cells (Senoo,
2013; Senoo et al., 2007). In line with these findings, in human
keratinocytes, nuclear YAP strictly co-localizes with p63abright
cells in vivo and proliferating p63abright cells located at the edge
of growing colonies, while p63adim/neg keratinocytes contain
only cytoplasmic, inactive P-YAP.2046 Cell Reports 27, 2036–2049, May 14, 2019Intriguingly, a dramatic difference exists between the expres-
sions of P-YAP and p63a in vivo and in vitro, depending upon the
age of the patient. The epidermal basal layer of all JEB patients
contains only (or mostly) cytoplasmic YAP, irrespective of the
age of the patient. Instead, basal p63abright keratinocytes are still
present in JEB newborns, but they progressively disappear dur-
ing the disease process and are still detectable in children and
almost undetectable in adults. In contrast, all primary JEB cul-
tures are formed by colonies containing P-YAP and low levels
of p63a, which causes rapid clonal conversion and senescence.
This notion explains the hurdles encountered in the isolation
and cultivation of JEB keratinocytes. While cultures can be rela-
tively easily initiated from infants, multiple biopsies are usually
required to initiate JEBcultures fromadults. In such patients, suc-
cessful cultures can be established only when biopsies are taken
from body sites less affected by the disease. However, JEB
epidermal cultures rapidly lose their stem cell content and un-
dergo premature senescence irrespectively of the age of the pa-
tients and the donor body site. Thus, it is tantalizing to speculate
that perhaps depending upon the type of mutation, there is a pro-
gressive, yet slow, YAP-dependent loss of JEB stem cells during
the disease process, and such loss is dramatically accelerated
during culture procedures. Accordingly, JEB patients slowly but
progressively lose their ability to heal their continuously occurring
skin blisters and eventually develop chronic non-healingwounds.
These findings have huge clinical implications. First, ideally,
ex vivo gene therapy should be performed as soon as possible
in children, before the exhaustion of stem cells occurring through
the disease process. Second, to minimize the rapid clonal
evolution and stem cells loss observed in culture, clonogenic ker-
atinocytes should be transduced immediately after their isolation
from the skin biopsy.When appropriately performed, ex vivo gene
therapy can in fact prevent the rapid loss of JEB stem cells occur-
ring during cultivation (refs and Figures 5 and 7). Third, the initial
cultivation step should be performed on laminin 332 coated
vessels to provide a laminin 332/a6b4 signal to JEB keratinocytes
even before gene correction to further minimize the stem cell loss
due to YAP dysregulation and to foster proliferation of the estab-
lished clonogenic cells (Figure 6A). These data are supported by
many lines of evidence on the use of laminin coating vessels
to sustain self-renewal and stem cell properties in other cellular
contexts (Rodin et al., 2010; Takayama et al., 2013).
In summary, our data show that signals emanating from laminin
332 at hemidesmosomes through a6b4 and not b1 underpin YAP
activity, which is instrumental in sustaining human epidermal
stem cells. LAMB3-dependent JEB triggers YAP inactivation
and leads to epidermal stem cell depletion, supporting the notion
that JEB is an adhesion and a stem cell disease. These findings
will drive a better development of combined ex vivo cell and
gene therapy for this devastating genetic skin disease.STAR+METHODS
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GIPZ non-silencing Lentiviral shRNA Control Dharmacon Cat# RHS4346
GIPZ Human WWTR1 shRNA #1 Dharmacon Cat# RHS4430-200267049
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human tissues
All human tissues were collected after informed consent and in compliance with Italian regulations (Comitato Etico Provinciale, C.E.
N. 178/09 and C.E. N. 124/2016), German (District Council of Arnsberg, North Rhine-Westphalia, Germany), and Austrian (Austrian
Ministry of Health) regulations.
Primary human cell cultures
Human skin samples were obtained as anonymised surgical waste, typically from abdominoplasty or mammoplasty. Briefly, skin
biopsies were minced and trypsinized (0.05% trypsin/0.01%EDTA) at 37C for 4 hr. Cells were collected every 30 min, plated
(2.53 104/cm2) on lethally irradiated 3T3-J2 cells (2.4 X 104/cm2) and cultured in 5%CO2 and humidified atmosphere in keratinocyte
growth medium (KGM): DMEM and and Ham’s F12 media (3:1 mixture) containing Fetal Bovine Serum (FBS) (10%), insulin (5 mg/ml),
adenine (0.18 mM), hydrocortisone (0.4 mg/ml), cholera toxin (CT, 0.1 nM), triiodothyronine (Liothyronine Sodium) (2 nM), epidermal
growth factor (EGF, 10 ng/ml), glutamine (4 mM), and penicillin-streptomycin (50 lU/ml) and cultivated on a feeder-layer of lethally
irradiated 3T3-J2 cells as described (Dellambra et al., 1998) . Subconfluent primary cultures were serially propagated as described
(De Luca et al., 1988; Mathor et al., 1996). For serial propagation, cells were passaged at the stage of subconfluence, until they
reached senescence (Pellegrini et al., 1999b).
Primary Junctional Epidermolysis Bullosa (JEB) and Dystrophic Epidermolysis Bullosa (RDEB) cell cultures
Primary EB keratinocytes were cultivated as described above from a 1-4cm2 biopsies taken (after informed consent) from 4 patients
suffering from LAMB3-dependent Junctional Epidermolysis Bullosa (JEB 2-5) and 2 patients suffering from Col7A1-dependent
Dystrophic Epidermolysis Bullosa (RDEB 1-2), ranging in age from 3months to 49 years(Bauer et al. 2017; Hirsch et al., 2017; Mavilio
et al., 2006) .e3 Cell Reports 27, 2036–2049.e1–e6, May 14, 2019
3T3J2 cell line
Mouse 3T3-J2 cells were a gift from Prof. Howard Green, Harvard Medical School (Boston, MA, USA). A clinical grade 3T3-J2 cell
bank was established under GMP standards by a qualified contractor (EUFETS, GmbH, Idar-Oberstein, Germany), according to
the ICH guidelines. GMP-certified 3T3-J2 cells have been authorized for clinical use by national and European regulatory authorities
and cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% irradiated donor adult bovine serum gamma
irradiated, glutamine (4 mM) and penicillin-streptomycin (50 IU/ml).
MFG-LAMB3-Packaging cell line
A retroviral vector expressing the full-length 3.6-kb LAMB3 cDNA under the control of the MLV LTR was constructed by cloning a
3.6-kb of LAMB3 cDNA (Gene Bank Accession #Q13751) into MFG-backbone (Markowitz et al., 1988). A 50 fragment of LAMB3
cDNA (563bp) from the ATG to StuI site was obtained by PCR using as template the LB3SN plasmid (Dellambra et al., 1998). The
PCR product was cloned into NcoI and BamHI sites of MFG-vector. The second fragment of LAMB3 cDNA (3050bp) was obtained
from LB3SN by enzyme digestion from StuI to XmnI and cloned into MGF-vector into StuI site. The entire cDNA of LAMB3 was fully
sequenced. The Am12-MGFLAMB3 producer cell lines (Mathor et al., 1996) were generated by transinfection in the amphotropic
Gp+envAm12 packaging cell line (Mathor et al., 1996). Briefly, plasmid DNA was introduced into the GP+E86 ecotropic packaging
cell line by standard calcium phosphate transfection. Forty-eighth ours after transfection, supernatant was harvested and used to
infect the amphotropic packaging cell line GP+envAml2 ATCC n CRL 9641(Markowitz et al., 1988) for 16h in the presence of 8
ug/ml Polybrene. Infected Am12 cells were clonally selected in HXM medium supplemented with 10% FCS and containing
0.8mg/ml G418 and 0.2mg/ml hygromycin B (Sigma). Single colonies were screened for human LAMB3 production by immunoflu-
orescence using an antibody specific for LAMB3 6F12 monoclonal antibody (from Dr. Patricia Rousselle, CNRS, Lyon) and for viral
titer. The resulting producer cell lines showed a viral titer of 2X106 colony-forming units (cfu). A master cell bank of a high-titer pack-
aging clone (Am12-LAMB3 2/8) was made under GMP standards by a qualified contractor (Molmed S.p.A, Milan, Italy) according to
the ICH guidelines and cultured in DMEM supplemented with 10% irradiated fetal bovine serum, glutamine (2 mM), and penicillin-
streptomycin (50 IU/ml). All certifications, quality and safety tests (including detection on viruses and other micro-organisms both
in vitro and in vivo) were performed under GMP standards for both cell lines.
METHOD DETAILS
Generation of genetically corrected epidermal keratinocytes
In brief, sub-confluent primary cultures derived from JEB skin biopsies were trypsinized (0.05% trypsin and 0.01%EDTA) at 37 C for
15–20 min and seeded (1.333 104 cells per cm2) onto a feeder layer (83 104 cells per cm2) composed of lethally irradiated 3T3-J2
cells and producer GP+envAm12-LAMB3 cells12 (a 1:2 mixture) in KGM. After 3 days of cultivation, cells were collected and cultured
in KGM on a regular 3T3-J2 feeder layer. At each step, efficiency of colony formation by keratinocytes was determined by plating
1,000 cells and staining them 12 days later with rhodamine B.
Colony Forming Efficiency, population doublings and growth rate
Colony forming efficiency of keratinocytes at each culture amplification was determined by plating 1000 cells on parallel 100-mm
dishes and staining them 12 days later with rhodamine B. Total colonies were calculated as a percentage of total plated cells; aborted
colonies (made by large and flattened, terminally differentiated cells) were calculated as a percentage of total colonies. The number of
cell generations performed by cultured keratinocytes was then calculated using the following formula: x = 3.322 logN/No, where N is
the total number of cells obtained at each passage and No is the number of clonogenic cells plated (Rochat et al., 1994). CFE was
determined during serial cultivation at each passage. Growth rates were calculated using the following formula log ((number of cells
obtained)/(number of cells seeded))/log(2) (Bisson et al., 2013).
Clonal analysis
Sub-confluent epidermal cultures were trypsinized, serially diluted and plated in 96-well plates (0.5-1 cells per well). After 7 days of
cultivation, single clones were identified under an inverted microscope and trypsinized. One-quarter of the clone was cultured for
12 days onto a 100-mm (indicator) dish, which was then fixed and stained with rhodamine B for the classification of clonal type
12-d after (Figure S1). The remaining three-quarters of the clonewas cultivated on 6-well plates for 4–5 days and then used to prepare
cell extracts for further analyses.
Western blotting
All samples destined towestern blot analysis were depleted of feeder layer by gently removal of feeder layer in cold PBS/EDTA 20mM
and then keratinocytes colonies were collected by scraping. Protein samples from whole cell (1 3 RIPA buffer, Sigma Aldrich),
nucleus/cytoplasmic (NE-PER, Thermo Fisher) were supplemented with Protease and Phosphatase Inhibitor Cocktail (Thermo
Fisher). Total protein amount was quantified in RIPA extracts using the BCA kit (Pierce). Equivalent quantities of RIPA-solubilized
proteins were resolved by SDS-PAGE in 4%–12% NuPAGE Bis-Tris Gels (ThermoFisher) and transferred 100V at 4C for 2 hours
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Albumin (BSA) in PBS supplemented with 0.05% (v/v) Tween-20 (PBS-T) and then probed with the indicated antibodies diluted in
blocking buffer. Primary antibody-probed blots were visualized with appropriate horseradish peroxidase-coupled secondary
antibodies (Santa Cruz). Protein detection was carried out using a chemiluminescent substrate (Thermo Fisher).
The following antibodies were used for western blot: p63a rabbit purified anti-p63a immunoglobulin G (IgG; PRIMM) (Di Iorio et al.,
2005), Yap (Millipore), Phospho-Yap Ser 127 (Cell Signaling), Survivin (Abcam), Taz (BD PharMingen), Laminin332-b3, p16 (Santa
Cruz), p53 (Santa Cruz), Integrin b1 (Abcam), Integrin b4 (Santa Cruz).
Immunofluorescence
The following antibodies were used for immunofluorescence: mouse 6F12monoclonal antibody to laminin 332-b3 (a gift fromPatricia
Rousselle, IBCP), Col7A1monoclonal antibody (Santa Cruz), rabbit purified anti-p63a immunoglobulin G (IgG; PRIMM) (Di Iorio et al.,
2005), 14-3-3-s (Abcam), YAP1 (Millipore), Phospho-Yap Ser 127 (Cell Signaling), YAP (Cell Signaling), alpha-Catenin (Abcam).
For immunofluorescence analysis cells were seeded at 1.000/wells onto glass coverslips and grown in the presence of feeder cells
in keratinocyte medium for 4, 6 or 10 days and then fixed with PFA 3% (10 min, at RT). The coverslips were carefully washed with
phosphate-buffered saline (PBS), permeabilized with PBS/triton 0.5% for 15 min and then blocked for 1 h at room temperature
with FBS 5%/2% BSA in PBS/triton 0.5%. Primary antibodies for immunofluorescence were incubated overnight in FBS 5%/2%
BSA in PBS/triton 0.5%. Alexa Fluor 568 donkey anti-mouse (Thermo Fisher), Alexa Fluor 488 donkey anti-rabbit (Thermo Fisher),
diluted 1:2.000 in 5% Goat serum, 2% BSA in PBS/triton 0.5% for 1h at RT. Cell nuclei were stained with DAPI. Glasses were
then mounted with Dako Mounting medium and fluorescent signals were monitored under a Zeiss confocal microscope
LSM510meta with a Zeiss EC Plan-Neofluar 40 3 /1.3 oil immersion objective or Zeiss Microscope AXIO ImagerA1 with EC-Plan
Neofluar 20 3 /0.5 objective or 10 3 /0.5 objective.
For in vivo immunofluorescence, skin biopsies derived from healthy donors or JEB 1, JEB2 and JEB3 were washed in PBS,
embedded in Killik-OCT cryostat embedding medium (Bio-Optica) and frozen. Immunofluorescence was performed on 7-mm skin
sections (fixed in PFA 3%, permeabilized with PBS/triton 0.2% for 15 min at room temperature and blocked for 1 h at room temper-
ature with BSA 2% in PBS/triton 0.2%) using the previous described antibodies in BSA 2% in PBS/triton 0.2% and added to skin
sections for 30 min at 37 C. Sections were washed three times in PBS/triton 0.1% and incubated with Alexa Fluor 568 donkey
anti-mouse (Thermo Fisher), Alexa Fluor 488 donkey anti-rabbit (Thermo Fisher), diluted 1:2.000 in BSA 2%, PBS/triton 0.2% for
30 min at 37 C. Cell nuclei were stained with DAPI. Glasses were thenmountedwith DakoMountingmedium and fluorescent signals
were monitored under a Zeiss confocal microscope LSM510meta with a Zeiss EC Plan-Neofluar 40 3 /1.3 oil immersion objective.
Senescence-Associated b-Galactosidase Staining
Cells were washed in PBS, fixed for 3-5 min at room temperature in 2% formaldehyde/0.2% glutaraldehyde, washed, and incubated
with staining solution at 37C (no CO2) from 2-4 hours to 12-16 hours. Staining solution contain: 40 mM citric acid/Na phosphate
buffer, 5 mM K4[Fe(CN)6] 3H2O, 5 mM K3[Fe(CN)6], 150 mM sodium chloride, 2 mM magnesium chloride and 1 mg ml
1 X-gal in
distilled water (Debacq-Chainiaux et al., 2009).
Plasmid constructs
For inducible expression of YAP constructs, cDNA for human HA-tagged -YAP1, YAP1S127A, YAP15SA (LATS mutant sites) and
human YAP1S94A (TEAD-binding mutant) (Panciera et al., 2016) (gifted from Stefano Piccolo) were subcloned NheI/Sal into
pCW57.1. HA-tag-eGFP was derived from p-babe pure, cloned into NheI blut/Sal into pCW57.1 and used as control. All constructs
were confirmed by sequencing. shRNA constructs were purchased from Dharmacon (Table S1).
Lentiviral production and primary human keratinocyte infection
HEK293T cells were kept in DMEM supplemented with 10% FBS, 1% Glutamine and 1% Pen/Strep antibiotics (Thermo Fisher).
Lentiviral particles were prepared by transiently transfecting HEK293T with lentiviral vectors together with packaging vectors
pMD2-VSVG and pPAX2 by using calcium phosphate transfection. Infectious lentiviruses were harvested after 48h post-transfection
and filtered through 0.45- mm-pore cellulose acetate filters. Recombinant lentiviruses were concentrated by ultracentrifugation.
Primary human keratinocytes were infected with the lentiviral particles at MOI10 in the presence of 8 mg/mL polybrene (Sigma).
The cells were harvested 5-6 days after transduction for further analyses.
Transient transfection
A total amount of 100nM siRNA (Stealth siRNA, Invitrogen) for YAP, TAZ, control medium GC rich and high GC rich siRNA (Stealth
siRNA, Invitrogen) (Table S2) were transfected by Lipofectamine RNAiMAX (Thermo Fisher). for 5h in the absence of serum. After 5h
the medium was changed and replacing in Kc medium. For LAMB3 and p63 a total amount of 100nM of specific siRNA (Silencer,
Invitrogen) was transfected (Table S3). The cells were collected 48h after transfection in RIPA buffer or in TriZol (Thermo Fisher).
RNA extraction and real-time qPCR
Total RNA was isolated from cultured cells using the PureLink RNA Mini Kit (Thermo Fisher). Complementary DNA was generated
using the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher). Real-time qPCR analyses were carried out on triplicate samplingse5 Cell Reports 27, 2036–2049.e1–e6, May 14, 2019
of retrotranscribed cDNAs with 7500 Real-Time PCR System (Thermo Fisher). Expression levels are given relative to GAPDH. List of
TaqMan probe (Thermo Fisher) are provided in Table S4.
Coating of Laminin 332
To culture JEB keratinocytes onto laminin 332-coated dishes, six well plates were coated with human recombinant laminin-332
(BioLamina, https://www.biolamina.com) diluted in DPBS at final concentration 1mg/cm2 and incubated overnight at +4C.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
GraphPad Prism version 7 was used for statistical analyzes included in the main and supplementary figures of the study. The
statistical details of the experiments including statistical tests used, value of n, and what n represents, can be found in the figure
legends. A *p value < 0.05, **p value < 0.01, ***p value < 0.001, and ****p value < 0.0001 were considered statistically significant.
RT-qPCR data are presented as the mean ± SEM of at least three independent experiments and the value of n can be found in
the figure legends. No statistical methods were used to predetermine sample sizes.
Replications
All experiments were replicated a number of times depending of the experiment performed. For qualitative data such as those
obtained from immunofluorescence, pictures are representative of what was observed in at least three independent samples or
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